Santhera Pharmaceuticals’ License Agreement With Sperogenix Therapeutics

Federica Tiefenthaler
Tagged:

chellenberg Wittmer advised Santhera Pharmaceuticals on the deal.Swiss Biotech Santhera has entered an exclusive licence agreement with China-based Sperogenix Therapeutics for the development of Vamorolone for…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

This content is for Standard 1 Year members only.
Login Join Now